Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Croda International PLC M&A Activity 2021

Jun 2, 2021

4641_tar_2021-06-02_413d39f3-64ca-425b-b3ad-46ff59559f1b.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 6301A

Croda International PLC

02 June 2021

Press Release

2 June 2021

Croda completes acquisition of Parfex

Croda International Plc ('Croda') today confirms that as of 1 June 2021, its wholly-owned Iberchem subsidiary successfully completed the acquisition of Parfex S.A. ('Parfex'), a fine fragrance business based in Grasse, France.

This follows the announcement on 7 April 2021 that Croda had reached an agreement to acquire Parfex. 

Croda has acquired a controlling majority 95.6% of Parfex's outstanding shares, comprising the founding shareholders and certain minority investors. Croda ultimately expects to acquire 100% of the total outstanding share capital, subject to a potential tender offer and subsequent de-listing.

-ENDS-

Further information:

Investors: David Bishop, Croda                                              +44 7823 874428

Media: Charlie Armitstead, Teneo                                          +44 7703 330269

About Croda:

Croda is the speciality chemicals company that uses smart science to create high performance ingredients and technologies that improve lives. For more information see: www.croda.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACQBSGDLSXGDGBD